Introduction
Methods
Identification and selection of studies
Inclusion and exclusion criteria
-
Participants: patients of all ages with NLBP for at least 6 weeks;
-
Intervention: WBVT therapy for a minimum duration of 2 weeks;
-
Control groups: no WBVT, basic physical therapy, no control group;
-
Outcomes: effects on pain, activities of daily living and physical activity, lumbar proprioception, and postural stability;
-
Study design: prospective, controlled, and uncontrolled studies, crossover design;
-
Language limitations: published in English or German.
Data collection and analysis
Results
Literature search
Clinical trail | Items on the PEDro scale | Total score | Level of quality | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |||
Wang et al. (2019) [15] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 9 | Good |
Wegener et al. (2019) [16] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 5 | Fair |
Kaeding et al. (2017) [17] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Pozo-Cruz et al. (2011) [18] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Rittweger et al. (2002) [19] | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | Fair |
Karacay et al. (2022) [20] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Yang et al. (2015) [21] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | Good |
Zheng et al. (2019) [22] | One-group intervention | – | – | ||||||||||
Micke et al. (2021) [23] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Kim et al. (2018) [24] | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 8 | Good |
Sajadi et al. (2019) [25] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | Good |
Park et al. (2022) [26] | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 7 | Good |
Study characteristics
Study | Population | Intervention | Outcome | Results/authors’ conclusion |
---|---|---|---|---|
Wang et al. (2019) [15] | Single-blind randomized controlled trial | |||
89 patients with NCLBP | 12 weeks 3 times per week 5 min warm up, 15 min exercises (6 dynamic and static movements: squat, kneeling, bridge, bridge with leg lift, bridge and knee flex, and back release) 5 min cool down | VAS ODI Joint position sense in flexion/extension Con-Trex isokinetic dynamometer SF36 Global perceived effect Adverse events | “The study provided evidence that whole-body vibration exercise could offer greater advantages compared to general exercise in terms of pain relief and improvement of functional disability in patients suffering from non-specific chronic low back pain.” [15] | |
Intervention group: 45 patients Mean age in years (SD): 21.64 (3.01) Gender m/f: 34/11 Dropout: 4 | BodyGreen 9 Hz: WBV | |||
Control group: 44 patients Mean age in years (SD): 22.02 (4.59) Gender m/f: 31/13 Dropout: 1 | Without vibration | |||
Wegener et al. (2019) [16] | Two-step prospective randomized parallel trial | |||
115 patients with and without non-specific chronic back pain | – | – | “In the study setting, the MFT-S3-Check did not detect a significant difference in postural stability between the group of individuals with back pain and the group without back pain. However, it was observed that postural stability improved after the implementation of treatment.” [16] | |
50 patients no back pain Mean age in years (SD): 61.2 (8.6) Gender m/f: 20/30 | – | MFT S3-Check (muscle-mediated spine stability): Trend Sport Trading GmbH, Großhöflein, Austria STI, SMI, SI | ||
65 patients with NSCBP Mean age in years (SD): 61.6 (7.9) Gender m/f: 20/45 Dropout: 11 | 18 weeks 3 × 6 weeks with increasing intensity and increasing time Twice a week 5 defined trunk stability exercises | MFT S3-Check ODI SF-36 physical/mental summary HADS NASS/back pain & neurological Symptoms | ||
Intervention group (WBV) Intervention group: 22 patients | Galileo® 5–20 Hz | |||
Control group (CPT) Control group: 22 patients | Weights and TheraBand® | |||
Kaeding et al. (2017) [17] | Randomized and controlled study | |||
41 patients with chronic low back pain | 12 weeks | RMQ ODI (%) Static posturography: Leonardo Mechanograph SF 36 (physical, mental health) WAI Freiburger activity questionnaire, Isokinetic performance of the musculature of the trunk Sick leave | “WBV training appears to be a beneficial, secure, and appropriate intervention for individuals with chronic low-back pain who engage in seated work.” [17] | |
Intervention group: 21 patients Mean age in years (SD): 46.4 (9.3) Gender m/f: 14/7 Dropout: 1 | Galileo® 10–30 Hz (increasing during the intervention), 1.5–3.5 mm, 2.5 times per week 15 min 5 sets with a duration of 60–120 s Basic position on the device: | |||
Control group: 20 patients Mean age in years (SD): 45.5 (9.1) Gender m/f: 14/6 Dropout: 1 | No treatment | |||
Pozo-Cruz et al. (2011) [18] | Single-blind randomized controlled trial | |||
50 patients with NCLBP | 12 weeks | RMQ (points) VAS ODI (%) Postural stability test: BIODex balance system PSTAntPost, PSTMedLat HRQoL T6MWT PILE Peripheral vibration sensibility: Vibratron II device | “A twelve-week program of low-frequency vibrating board therapy is viable and potentially offers a new approach to physical therapy for individuals with non-specific low back pain.” [18] | |
Intervention group: 25 patients Mean age in years (SD): 58.71 (4.59) Gender m/f in %: 28/72 | Galileo® 20 Hz Twice a week with increasing time per series (60–360 s), decreasing repetition (6-1) Basic static position with 120° knee angle | |||
Control group: 25 patients Mean age in years (SD): 59.53 (5.47) Gender m/f in %: 26/74 Dropout: 1 | No treatment | |||
Rittweger et al. (2002) [19] | Randomized and controlled study | |||
60 patients with CLBP | 12 weeks, 2nd follow-up after 6 months Twice a week first 6 weeks Once a week last 6 weeks | P‑VAS PDI Isometric lumbar extension torque: Le Mark 1 lumbar extension machine ROM lumbar flexion and extension: Le Mark 1 lumbar extension machine | “The existing data suggest that diminished lumbar muscle strength is likely not the sole underlying factor responsible for chronic lower back pain. Various forms of exercise therapy appear to produce similar outcomes. Interestingly, well-regulated vibration may serve as a solution rather than a trigger for lower back pain.” [19] | |
Intervention group: 30 patients Mean age in years (SD): 54.1 (3.4) Gender: 15/15 Dropout: 5 | Galileo® 18 Hz, 6 mm 2 min warmup Max. 7 min intervention: slow movements of the hips, waist with bending and rotation | |||
Control group: 30 patients Mean age in years (SD): 49.8 (6.6) Gender: 15/15 Dropout: 5 | LE Mark 1 Isodynamic lumbar extension exercises 1 min warmup with lumbar extension Repetitive contraction cycles at a constant speed with a torque corresponding to 50% of the baseline maximum isometric values | |||
Karacay et al. (2022) [20] | Randomized controlled trial | |||
84 patients with NCLBP | 8 weeks, 2nd follow-up after 3 months 3 times a week | VAS RMQ PILE IMS: CybexTM Human Norm 350 | “In the treatment of NLBP, WBV and core stabilization exercise (CSE) appear to be effective in reducing pain and improving functionality. While there was a significant improvement in muscle strength and functional work performance in all three groups, the WBVE group and CSE group showed greater improvements compared to the control group (CG).” [20] | |
Intervention group: WBV 28 patients Mean age in years (SD): 43.3 (9.2) Gender m/f: 5/20 Dropout: 3 | Power plate®: 25 Hz, 2 mm 5 min warmup 3 different static positions, 30–60 s per position (squat, bridge, push-up) + classic lumbar home exercises | |||
Control group 1: CSE 28 patients Mean age in years (SD): 47.2 (8.0) Gender m/f: 2/23 Dropout: 3 | 5 min warmup, 30 min core stabilization exercises + classic lumbar home exercises | |||
Control group 2: CG 28 patients Mean age in years (SD): 43.6 (9.4) Gender m/f: 5/19 Dropout: 4 | Classic lumbar home exercises | |||
Yang et al. (2015) [21] | Randomized controlled trial | |||
40 patients with LBP No dropout | 3 weeks 3 times a week | VAS ODI FI: Tetrax KA: 3D tomography LA: 3D tomography | “WBV can be recommended as a therapeutic intervention for improving balance ability and alleviating pain in patients with chronic lower back pain.” [21] | |
Intervention group: 20 patients Mean age in years: 32.80 Gender m/f: 12/8 | Galileo® 18 Hz 5 min of WBV Static standing position 25 min of lumbar stability training with pressure biofeedback | |||
Control group: 20 patients Mean age in years: 30.95 Gender m/f: 9/11 | 30 min of lumbar stability training with pressure biofeedback | |||
Zheng et al. (2019) [22] | One group pre-test, post-test | |||
43 patients with NCLBP Mean age in years (SD): 21.6 (3) Gender m/f: 32/10 Dropout n =1 | 12 weeks BodyGreen: 9 Hz, 2 mm 3 times a week 5 min warmup, 18 min training (6 postures: squat, kneeling, bridge, bridge with leg lift, bridge and knee flex, and back release) 5 min cool down | VAS Lumbar joint position sense: Con-Trex Multi Joint system (Switzerland) | “After a 12-week WBV exercise, lumbar flexion and extension proprioception, as measured by joint position sense, showed significant improvement, and pain levels were significantly reduced in patients with NSLBP. However, it was observed that patients with already good flexion proprioceptive ability had limited enhancement in proprioception.” [22] | |
Micke et al. (2021) [23] | Three-armed randomized controlled trial | |||
240 chronic NLBP | 12 weeks | NRS (diary during the last four weeks of intervention) Trunk extension strength: BackCheck | “WB-EMS, WBV, and conventional training (CT) have demonstrated comparable effectiveness in improving maximum power input (MPI) and trunk strength. However, the training volume of WB-EMS was found to be 43 or 62% lower compared to CT and WBV, respectively.” [23] Bias: Change of intake of analgesics Start of additional treatment during the intervention (26 participants) | |
Intervention group: WBV 80 patients Mean age in years: 54.30 Gender m/f: 30/50 Dropout: 10 | Wellengang: 5–10 Hz, 9 mm Twice a week 15 min 5 exercises dynamic and static: dynamic cable squats, squats with arm extension, calf raises, static squats with arm movement, and static cable squats with calf raises | |||
Control group 1: WB-EMS 80 patients Mean age in years: 54.10 Gender: 30/50 Dropout: 7 | WB EMS Once a week 20 min 6 trunk-specific exercises | |||
Control group 2: CT 80 patients Mean age in years: 58.3 Gender m/f: 32/48 Dropout: 10 | Once a week 45 min, 15 min warmup, 30 min circuit training with static and dynamic exercises | |||
Kim et al. (2018) [24] | Randomized controlled trial | |||
28 patients with CLBP Dropout: 4 | 12 weeks, 2nd follow-up after 4 weeks 3 times a week 30 min 5 min warmup and cool down 20 min static posture | VAS ODI Standing balance: Biodex Stability System (Biodex Medical Systems). Muscle strength lumbar: isokinetic dynamometer Thickness TrA, MF: ultrasound | “HVE is shown to be equally effective as VVE in reducing pain, strengthening the lumbar muscles, and improving balance and functional abilities in patients with CLBP. Vibrational exercise has the ability to increase muscle strength without inducing muscle hypertrophy.” [24] | |
Group A: HVE 14 patients Mean age in years (SD): 55.1 (11.2) Gender m/f: 4/10 | Horizontal vibration exercise 3–5 Hz 1–48 mm 3 times a week Vibration in anteroposterior and in mediolateral directions | |||
Group B: VVE 14 patients Mean age in years (SD): 53.7 (12.1) Gender m/f: 3/11 | Vertical vibration exercise 28–34 Hz, 2.5–5 mm | |||
Sajadi et al. (2019) [25] | Randomized crossover trial | |||
24 patients with CLBP Mean age in years (SD): 25.2 (2.6) Gender m/f: 12/12 No dropout | Two sessions with 2 weeks of rest between them Power Plate®: LF (30 Hz), HF (50 Hz), 2.5 mm Semi-squat position 5 × 1 min with 1 min rest | VAS RE recorded in neutral, 30% and 60% of its maximum available range before and 5 min after WBV: electrogoniometer | “In this study, the method of WBV used, low-frequency WBV, appears to lead to greater improvement in the accuracy of lumbopelvic repositioning compared to high-frequency WBV.” [25] | |
Group A: 12 patients: First session with LF WBV, second session with HF WBV | ||||
Group B: 12 patients: first session with HF WBV, second session with LF WBV | ||||
Park et al. (2022) [26] | Randomized controlled trial | |||
48 patients with LBP | 5 weeks 60 min, 3 times a week 6 dynamic exercises Per exercise: 5 repetitions in a set, 10 s for each set, and 5 sets total | 4‑item visual analogue scale (QVAS) RMQ Static balance ability: Wii Balance board (Nintendo Kyoto, Japan) Center of pressure velocity Center of pressure Length Center of pressure area FABQ-PA, FABQ‑W, FVC, FEV1, FEV1/FVC MVV MEP MIV | “The implementation of a stabilization exercise program that incorporates respiratory resistance and whole-body vibration, tailored to the specific objectives of the intervention, appears to be an effective exercise regimen for individuals with lumbar instability.” [26] | |
Intervention group: SERW 16 patients Mean age in years (SD): 30.93 (4.70) Gender m/f: 8/6 Dropout: 2 | SW-VH11, Wonju, Korea, 30 Hz Stabilization exercise + WBV + respiratory resistance (SERW) | |||
Control group 1: SER 16 patients Mean age in years (SD): 31.07 (6.82) Gender m/f: 9/5 Dropout: 2 | Stabilization exercise + respiratory resistance (SER) | |||
Control group 2: SE 16 patients Mean age in years (SD): 30.29 (5.34) Gender m/f6/8 Dropout: 1 | Stabilization exercise (SE) |
Participants
Intervention
Outcome
Primary evaluated outcomes: pain intensity, impact on activities of daily living and physical function
Author | Time period | Tests | Groups | Initial | Follow up | P-value | Effect size | Between-group difference (95% CI) | |
---|---|---|---|---|---|---|---|---|---|
Wang et al. [15] | 12 weeks | VAS adjusted (ITT) | Intervention (n = 45) | 4.39 (4.16–4.61) | 2.87 (2.53–3.21) | < 0.001e | −1.04 | −1 (−1.22, −0.78) | |
Control (n = 44) | 4.05 (3.83–4.29) | 3.87 (3.53–4.21) | |||||||
ODI adjusted (ITT) | Intervention (n = 45) | 32.46 (30.22–34.71) | 19.46 (17.69–21.24) | < 0.001e | −0.75 | −3.81 (−4.98, −2.63) | |||
Control (n = 44) | 32.18 (29.91–34.5) | 23.27 (21.47–25.07) | |||||||
VAS unadjusted | Intervention (n = 45) | – | – | < 0.001e | – | 0.89 (−1.41 to −0.36) | |||
Control 0 (n = 44) | – | – | |||||||
ODI unadjusted | Intervention (n = 45) | – | – | < 0.001e | – | −3.81 (−6.68 to −0.92) | |||
Control (n = 44) | – | – | |||||||
VAS | Global perceived effect and minimal clinically important difference | ||||||||
Intervention (n = 45) | Control group (n = 44) | – | 0.001e | – | 4.7 (1.79 to 12.33)c | ||||
Benefit | 23 (51.1) | 8 (18.2) | – | – | – | – | |||
No benefit | 22 (48.9) | 36 (81.8) | – | – | – | – | |||
ODI | Global perceived effect and minimal clinically important difference | ||||||||
Intervention (n = 45) | Control group (n = 44) | – | 0.013e | – | 3.01 (1.24–7.31)c | ||||
Benefit | 33 (73.3) | 21 (47.7) | – | – | – | – | |||
No benefit | 12 (26.7) | 23 (52.3) | – | – | – | – | |||
Wegener et al. [16] | 18 weeks | ODI | – | 0.304e | – | – | |||
Intervention (n = 22) | 18.1 (12.0) | 17.1 (11.9) | 0.185f | – | – | ||||
Control (n = 22) | 20.7 (11.4) | 16.6 (12.3) | 0.876f | – | – | ||||
Kaeding et al. [17] | 12 weeks | ODI PP population | – | – | – | 0.002d,e < 0.001a,e | – | 2.7 (1.3–4.2) (PP) | |
Intervention (n = 21) | 17.2 (9.2) | 12.3 (7.4) | – | – | 4.5 (6.6)b | ||||
Control (n = 20) | 15.7 (7.1) | 17.3 (6.8) | – | – | −1.2 (3.2)b | ||||
RMQ ITT population | – | – | – | 0.043d,e 0.027a,e | 0.69 | 1.8 (0.2–3.4) (PP) | |||
Intervention (21) | 4.0 (3.8) | 2.3 (2.9) | – | – | 1.5 (2.6)b | ||||
Control (20) | 3.5 (2.3) | 4.0 (2.4) | – | – | −0.3 (2.6)b | ||||
RMQ PP population | – | – | – | 0.072d,e 0.008a,e | – | – | |||
Intervention (19) | 4.0 (3.8) | 1.7 (1.8) | – | – | – | ||||
Control (16) | 3.5 (2.3) | 3.6 (2.5) | – | – | – | ||||
Pozo-Cruz et al. [18] | 12 weeks | VAS | – | – | – | 0.006 (24.13%)e | −0.85 | −9.40 (2.94 to 16.05)g | |
Intervention (25) | 38.36 (15.85) | 29.00 (13.02) | – | – | – | ||||
Control (25) | 39.65 (13.26) | 39.68 (14.77) | – | – | – | ||||
ODI | – | – | – | 0.013 (25.15%)e | −0.72 | −6.3 (−13.7 to −1.70)g | |||
Intervention (25) | 26.50 (17.00) | 20.28 (10.89) | – | – | – | ||||
Control (25) | 29.16 (15.78) | 29.24 (15.64) | – | – | – | ||||
RMQ | – | – | – | 0.001 (9.31%)e | −1.01 | −1.12 (−2.42 to 0.96)g | |||
Intervention (25) | 11.63 (8.35) | 10.47 (8.68) | – | – | – | ||||
Control (25) | 12.44 (4.46) | 12.40 (4.50) | – | – | – | ||||
Rittweger et al. [19] | 12 weeks | VAS | – | – | – | > 0.2e | – | – | |
Intervention (25) | 4.16 (1.86) | 1.40 (1.83) | < 0.001f | – | – | ||||
Control (25) | 4.52 (2.21) | 1.20 (1.76) | < 0.001f | – | – | ||||
Karacay et al. [20] | 8 weeks Second follow-up after 3 months | VAS in rest/VAS in activity (PP) | – | – | – | 0.023e | – | – | |
Intervention (25) | 3.0 (1.5)/5.5 (1.5) | – | < 0.001f | – | – | ||||
Control (25) | 3.2 (1.9)/5.5 (1.7) | – | < 0.001f | – | – | ||||
Control 2 (24) | 3.7 (1.9)/6.0 (1.7) | – | 0.214f | – | – | ||||
RMQ (PP) | – | – | – | Follow up after 3 months | 0.73e | – | Difference pretreatment–posttreatment 3rd month | ||
Intervention (25) | 4.82 (3.97)/ | 1.86 (2.63) | 1.47 (1.90) | < 0.001f | – | 3.34 (3.73)b | |||
Control (25) | 4.44 (4.9) | 2.44 (3.16) | 1.80 (2.02) | < 0.001f | – | 2.64 (3.69)b | |||
Control 2 (24) | 6.30 (6.03) | 4.91 (4.28) | 5.26 (5.41) | 0.427f | – | 1.04 (6.57)b | |||
Yang et al. [21] | 3 weeks | VAS | – | – | – | < 0.005e | – | – | |
Intervention (n = 20) | 5.60 (1.60) | 2.70 (1.26) | < 0.001f | – | – | ||||
Control (n = 20) | 5.25 (1.12) | 3.50 (1.12) | < 0.001f | – | – | ||||
ODI | – | – | – | Not significant | – | – | |||
Intervention (n = 20) | 17. 85 (11.09) | 12.45 (6.06) | < 0.001f | – | – | ||||
Control (n = 20) | 15.30 (7.57) | 12.80 (6.67) | < 0.001f | – | – | ||||
Zheng et al. [22] | 12 weeks | VAS | Intervention (42) | 4.62 (1.23) | 3.0 (1.38) | 0.0001f | 0.96 | −28.3 (47.9)b | |
Micke et al. [23] | 12 weeks | NRS | – | – | – | 0.934e | – | – | |
Intervention (n = 80) | 2.94 (1.51) | – | < 0.001f | – | 30.3 (39.3%)b | ||||
Control (n = 80) | 3.08 (1.89) | – | < 0.001f | – | 29.7 (39.1%)b | ||||
Control 2 (n = 80) | 3.10 (1.57) | – | < 0.001f | – | 30.5 (39.6%)b | ||||
Kim et al. [24] | 4 weeks Second follow-up after 1 month | VAS | – | – | – | Posttreatment 1 month | 0.929e | – | – |
Horizontal (n = 14) | 4.30 (1.50) | 2.00 (0.90) | 2.60 (1.00) | 0.001f | – | – | |||
Vertical (n = 14) | 4.90 (1.90) | 2.80 (1.30) | 3.10 (1.50) | 0.001f | – | – | |||
ODI | – | – | – | – | 0.595e | – | – | ||
Horizontal (n = 14) | 21.57 (4.11) | 14.57 (3.67) | 14.71 (5.47) | 0.001f | – | – | |||
Vertical (n = 14) | 22.36 (6.76) | 16.21 (4.02) | 17.43 (5.42) | 0.001f | – | – | |||
Sajadi et al. [25] | 2 weeks | VAS | – | – | – | No significance | – | – | |
LF WBV (n = 24) | 45.8 (10.2) | 36.6 (7.8) | 0.000f | – | 9.22b | ||||
HF WBV (n = 24) | 45.8 (10.2) | 34.7 (8.7) | 0.000f | – | 11.05b | ||||
ODI | LF WBV (n = 24) | 12.46 (8.51) | – | – | – | – | |||
HF WBV (n = 24) | 12.46 (8.51) | – | – | – | – | ||||
Park et al. [26] | 2 weeks | QVAS | – | – | – | – | – | Post–Pre | |
SERW (n = 16) | 6.41 (0.43) | 4.59 (0.39) | 0.000f | – | −1.82 (0.58)b | ||||
SER (n = 16) | 6.45 (0.44) | 4.66 (0.409) | 0.000f | – | −1.79 (0.43)b | ||||
SE (n = 16) | 6.46 (0.46) | 5.96 (0.87) | 0.035f | – | −0.5 (0.79)b | ||||
RMQ | SERW (n = 16) | 21.29 (1.59) | 10.29 (1.27) | 0.000f | – | −11 (0.96)b | |||
SER (n = 16) | 21.43 (1.60) | 10.14 (1.17) | 0.000f | – | −11.29 (1.14)b | ||||
SE (n = 16) | 21.14 (1.61) | 13.07 (1.44) | 0.000f | – | −8.07 (1.86)b |
Secondarily evaluated outcomes: trunk proprioception, postural stability
Author | Tests | Groups | Initial | Follow-up | p-value | Effect size | Between-group difference (95% CI) | ||
---|---|---|---|---|---|---|---|---|---|
Wang et al. [15] | Joint position sense Flexion Adjusted | Intervention (n = 45) | 3.55 (2.82, 4.28) | 1.91 (1.36, 2.44) | 0.005a | −1.14 | 1.76 (−2.11, −1.4) | ||
Control (n = 44) | 3.96 (3.22, 4.7) | 3.67 (3.12, 4.21) | |||||||
Joint position sense Extension Adjusted | Intervention (n = 45) | 2.96 (2.23, 3.64) | 1.66 (1.17, 2.15) | 0.036a | −0.78 | −1.1 (−1.42, −0.77) | |||
Control (n = 44) | 3.06 (2.37, 3.74) | 2.76 (2.26, 3.26) | |||||||
Joint position sense Flexion unadjusted | Intervention (n = 45) | – | – | 0.003a | – | – | |||
Control (n = 44) | – | – | |||||||
Joint position sense Extension unadjusted | Intervention (n = 45) | – | – | 0.016a | – | – | |||
Control (n = 44) | – | – | |||||||
Wegener et al. [16] | STI standing (PP) | NBP (n = 50) | 5.1 (1.0) | – | – | – | – | ||
BP (n = 65) | 5.0 (1.3) | – | 0.885a | – | – | ||||
Intervention group (n = 17) | 5.0 (1.0) | 4.4 (1.1) | 0.052b | – | – | ||||
Control group (n = 16) | 5.6 (1.5) | 4.8 (1.4) | 0.012b | – | – | ||||
STI seated (PP) | NBP (n = 50) | 3.6 (2.0) | – | – | – | – | |||
BP (n = 65) | 4.0 (2.4) | – | 0.516a | – | – | ||||
Intervention group (n = 17) | 3.9 (2.1) | 2.9 (2.4) | 0.073b | – | – | ||||
Control group (n = 16) | 4.9 (2.9) | 2.6 (2.3) | 0.015b | – | – | ||||
SMI standing (PP) | NBP (n = 50) | 4.1 (1.2) | – | – | – | – | |||
BP (n = 65) | 4.3 (1.3) | – | 0.493a | – | – | ||||
Intervention group (n = 17) | 4.0 (1.2) | 3.4 (1.2) | 0.080b | – | – | ||||
Control group (n = 16) | 5.0 (1.2) | 4.0 (1.2) | 0.006b | – | – | ||||
SMI seated (PP) | NBP (n = 50) | 2.9 (1.7) | – | – | – | – | |||
BP (n = 65) | 3.4 (2.3) | – | 0.217a | – | – | ||||
Intervention group (n = 17) | 2.9 (1.9) | 2.0 (1.6) | 0.065b | – | – | ||||
Control group (n = 16) | 4.1 (2.7) | 2.0 (1.8) | 0.004b | – | – | ||||
SI standing right (PP) | NBP (n = 50) | 48.5 (12.6) | – | – | – | – | |||
BP (n = 65) | 49.9 (9.7) | – | 0.718a | – | – | ||||
Intervention group (n = 22) | 52.2 (13.0) | 47.8 (14.4) | 0.245b | – | – | ||||
Control group (n = 22) | 49.3 (7.5) | 50.8 (10.3) | 0.594b | – | – | ||||
STI standing left (PP) | NBP (n = 50) | 51.6 (13.1) | – | – | – | – | |||
BP (n = 65) | 50.1 (9.7) | 52.2 (14.4) | 0.718a | – | – | ||||
Intervention group (n = 22) | 47.8 (13.0) | 52.2 (14.4) | 0.245b | – | – | ||||
Control group (n = 22) | 50.7 (7.5) | 49.3 (10.3) | 0.594b | – | – | ||||
SI seated right (PP) | NBP (n = 50) | 57.2 (16.2) | – | – | – | – | |||
BP (n = 65) | 50.7 (15.4) | – | 0.773a | – | – | ||||
Intervention group (n = 22) | 48.3 (22.0) | 51.7 (21.9) | 0.865b | – | – | ||||
Control group (n = 22) | 55.5 (15.1) | 54.1 (17.5) | 0.754b | – | – | ||||
STI seated left (PP) | NBP (n = 50) | 42.8 (16.2) | – | – | – | – | |||
BP (n = 65) | 49.3 (15.4) | – | 0.773a | – | – | ||||
Intervention group (n = 22) | 51.7 (22.0) | 51.7 (21.9) | 0.865b | – | – | ||||
Control group (n = 22) | 44.5 (15.1) | 45.9 (17.5) | 0.754b | – | – | ||||
Kaeding et al. [17] | Static posturography: there were no significant differences in the tests with eyes open or with eyes closed in any of the measured parameters between the groups after 3 months of EBV training | ||||||||
Pozo-Cruz et al. [18] | PSTAntPost | Intervention (n = 25) | 0.52 (0.22) | 0.41(0.95) | 0.031a (ANOVA) | −3.74 | −0.11 (−0.22 to 0.00)d | ||
Control (n = 24) | 0.57 (0.40) | 0.57 (0.40) | |||||||
PSTMedLat | Intervention (n = 25) | 0.33 (0.17) | 0.30 (0.21) | 0.422a | −0.20 | −0.03 (−0.13 to −0.05)d | |||
Control (n = 24) | 0.47 (0.36) | 0.47 (0.37) | |||||||
Yang et al. [21] | Fall index | – | – | – | < 0.05a | – | – | ||
Intervention (n = 20) | 30.59 (14.97) | 12.80 (10.39) | < 0.001b | – | – | ||||
Control group (n = 20) | 23.40 (12.73) | 21.69 (12.68) | – | – | – | ||||
Zheng et al. [22] | Flexion angle deviation | Intervention group (42) | 3.65 (2.26) | 1.90 (1.07) | 0.0001b | −26.4e (57.7) | 0.75f | ||
Extension angle deviation | Intervention group (42) | 3.06 (1.85) | 1.61 (0.75) | 0.0001b | −35.9 (27.9)e | 0.83f | |||
Kim et al. [24] | Anterior/posterior | – | Follow up after 1 month | 0.647a | – | – | |||
Horizontal vibration | 3.86 (1.23) | 2.38 (0.71) | 2.50 (0.67) | < 0.001b,c | – | – | |||
Vertical vibration | 4.00 (0.80) | 2.52 (0.71) | 2.41 (0.65) | < 0.001b | – | – | |||
Medial/lateral | – | 0.522a | – | – | |||||
Horizontal vibration | 3.83 (1.26) | 2.23 (0.79) | 2.28 (0.71) | < 0.001b | – | – | |||
Vertical vibration | 3.89 (1.79) | 2.25 (0.79) | 2.19 (0.71) | < 0.001b | – | – | |||
Sajadi et al. [25] | 0° | – | 0.000a,g | – | 1.4g | ||||
LF | −2.91 (0.57) | −1.47 (0.88) | < 0.001b | – | 1.4f | ||||
HF | −2.51 (0.87) | −2.26 (0.99) | < 0.001b | – | −0.65f | ||||
30° | – | 0.6a,g | – | 0.67g | |||||
LF | 13.6 (1.97) | 14.6 (1.47) | 0.05b | – | −0.9f | ||||
HF | 13.53 (1.67) | 14.2 (1.54) | 0.1b | – | −0.5f | ||||
60° | – | 0.06a,g | – | 0.7g | |||||
LF | 29.7 (3.97) | 28.48 (2.78) | 0.04b | – | 0.73f | ||||
HF | 29.2 (3.17) | 28.63 (3.17) | 0.2b | – | 0.57f | ||||
Park et al. [26] | CoP velocity | – | 0.039a,h | – | – | ||||
SERW (n = 14) | 4.69 (0.69) | 3.50 (0.65) | 0.000b | – | −1.19 (0.86)f | ||||
SER (n = 14) | 4.78 (0.71) | 4.02 (0.79) | 0.002b | – | −0.76 (0.75)f | ||||
SE (n = 15) | 4.81 (0.69) | 4.35 (0.57) | 0.010b | – | −0.46 (0.57)f | ||||
CoP length | – | 0.003a,h | – | – | |||||
SERW (n = 14) | 142.61 (2019) | 108.41 (4.99) | 0.000b | – | −34.20 (20.34)f | ||||
SER (n = 14) | 142.69 (2212) | 128.83 (16.32) | 0.027b | – | −15.29 (23.02)f | ||||
SE (n = 15) | 144.95 (22.37) | 136.86 (16.13) | 0.032b | – | −8.09 (12.57)f | ||||
CoP area | – | 0.048a,h | – | – | |||||
SERW (n = 14) | 9.79(2.33) | 6.01(2.79) | 0.000b | – | −3.78 (2.61)f | ||||
SER (n = 14) | 8.89 (2.60) | 6.58 (2.65) | 0.004b | – | −2.31 (2.45)f | ||||
SE (n = 15) | 9.29 (2.70) | 7.87 (2.24) | 0.037b | – | −1.42 (2.29)f |